UNSPSC 85892416: High dose rate (hdr) brachytherapy of eye using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of eye using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D81099Z

UNSPSC 85892416 High dose rate (HDR) brachytherapy of eye using iodine 125 (I-125) is a Commodity code showing minimal recent state and local procurement activity aligned with its nominal scope. The single recent opportunity on record—County of Santa Clara Health System solicitation RFSQHHSFY270052, posted July 7, 2026—requests temporary health professional staffing services across thirteen ancillary clinical categories including Audiology, Cardiology and Vascular, Diagnostic Imaging/Radiology, Gastroenterology, Ophthalmology, Orthopedic, Respiratory Care, Sterile Processing, and Surgical/Operating Room services, with proposals due October 7, 2026. This solicitation establishes a non-exclusive, multiple-award qualified vendor pool with no guaranteed work; the Health System may maintain the list for five years and contract with selected vendors as operational needs arise. Proposers may self-select and submit qualifications for all or specific health professional categories without penalty for single-specialty focus. The explicit scope excludes nursing, physician, and other non-clinical staffing, and qualifications will be negotiated between each selected vendor and the County on a case-by-case basis.

The code's recent activity is concentrated in California, sourced from a single county health system. The Santa Clara opportunity is structured as an RFQ-type qualification vehicle rather than a traditional project or service procurement, and does not directly align with the code's nominal focus on specialized ophthalmic brachytherapy procedures. The mismatch between the code's clinical specificity and the broad ancillary staffing scope of the posted opportunity suggests potential misclassification or limited use of this code for state and local buying. Firms pursuing ophthalmic oncology or radiation therapy staffing should monitor Santa Clara and similarly positioned health systems, though the code itself shows little other recent activity.